Browsing by Author "Suresh, S."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Alpha thalassaemia and extended alpha globin genes in Sri Lanka
    (Elsevier-Academic Press, 2013) Suresh, S.; Fisher, C.; Ayyub, H.; Premawardhena, A.; Allen, A.; Perera, A.; Bandara, D.; Olivieri, N.; Weatherall, D.
    The α-globin genes were studied in nine families with unexplained hypochromic anaemia and in 167 patients with HbE β thalassaemia in Sri Lanka. As well as the common deletion forms of α(+) thalassaemia three families from an ethnic minority were found to carry a novel form of α(0) thalassaemia, one family carried a previously reported form of α(0) thalassaemia, --(THAI), and five families had different forms of non-deletional thalassaemia. The patients with HbE β thalassaemia who had co-inherited α thalassaemia all showed an extremely mild phenotype and reduced levels of HbF and there was a highly significant paucity of α(+) thalassaemia in these patients compared with the normal population. Extended α gene arrangements, including ααα, αααα and ααααα, occurred at a low frequency and were commoner in the more severe phenotypes of HbE β thalassaemia. As well as emphasising the ameliorating effect of α thalassaemia on HbE β thalassaemia the finding of a novel form of α(0) thalassaemia in an ethnic minority, together with an unexpected diversity of forms of non-deletion α thalassaemia in Sri Lanka, further emphasises the critical importance of micro-mapping populations for determining the frequency of clinically important forms of the disease.
  • Thumbnail Image
    Item
    An attempt to establish a cutoff value for peripheral blood hematopoietic progenitor cell count to predict the viable CD34 count in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
    (Faculty of Science, University of Kelaniya Sri Lanka, 2023) Hewapathirana, T. D.; Perera, T. C.; Tudugala, R.; Suresh, S.; Kottahachchi, D. U.
    Multiple myeloma (MM) is a common hematological malignancy characterized by the proliferation of abnormal plasma cells in the bone marrow, leading to immune dysfunction and bone damage. Autologous peripheral blood stem cell transplantation (aPBSCT) is a pivotal treatment for MM, extending survival rates. The success of aPBSCT relies on the composition of the mobilized peripheral blood cells, particularly the hematopoietic progenitor cells in peripheral blood (HPC_PB). In aPBSCT, viable CD34 cell count (V_CD34) which is enumerated by the flow cytometer (FC) is used to calculate the minimum stem cell yield required for a successful transplantation. Therefore, detecting the optimal HPC_PB count in relation to V_CD34 is crucial for enhancing the effectiveness of aPBSCT and also for the proper management of MM patients. To establish a cutoff value for HPC_PB using an automated hematology analyzer (AHA) as a predictor for V_CD34 in the peripheral blood of MM patients undergoing aPBSCT. This initiative aims to replace or supplement the flow cytometry (FC) facility with AHA, as AHA provides a cost-effective, user-friendly, faster, and more accessible method for assessing cellular profiles during PBSCT. This transition addresses the limitations of the FC technique, which encompass high expenses, complexity, the demand for specialized personnel, substantial sample sizes, timeintensive procedures, and restricted availability. MM patients representing males (n=23) and females (n=22) at the age of 40-65 years, admitted to the Bone Marrow Transplant Unit (BMTU) in Apeksha Hospital, Maharagama, Sri Lanka were selected for the study (n=45). The ninth day from the mobilization of the bone marrow cells was considered as the day of harvesting. The Sysmax-1000 AHA was used to enumerate HPC_PB and, V_CD34_PB was enumerated by flow cytometer (FC) BDACS Lytic TM using already collected samples for routine testing. First, the data were separately tested for normalization, followed by correlation bivariate analysis and, Receiver Operating Characteristic (ROC) curve analysis to establish relationships and cutoff values for HPC_PB respectively. In the ROC analysis, the two groups of V_CD34_PB were defined as; Group 1 =90 cells/µL.In the statistical analysis, the HPC_PB_AHA showed normal distribution while V_CD34_PB_FC did not follow it. HPC_PB possessed a significant (p=0.000) strong positive Spearman bivariate correlation (r = 0.930) with the V_CD34_PB. The cutoff value obtained for the HPC_PB is 89 cells/µL, at V_CD34_PB of 90 cells/µL with sensitivity (97.1%), specificity (99.9%), and area under the curve of 0.978 with statistically significant (p=0.022